Production & Process Engineering
InnoMedica has built its own production facilities, and maintained them according to GMP standards, right from the start. A strategy which pays off. Today, ten people are already employed in GMP production and process engineering bringing valuable know-how inside our company. With a view to future market approval of the products, the expansion of the infrastructure in Marly began in 2018 and a new, larger clean room has been built, which was put into operation in 2021.
Dr. Thomas Schick is head of the production team that produces InnoMedica's drugs under GMP conditions for use in the clinic since the end of 2020. With the new, larger Clean Room II, the production capacities are increasing, so the production team is continuously working on making our manufacturing processes more efficient.
Dr. Matthias Burgener and his team in the Process Engineering department enable the products developed by the research team to be translated into a routine GMP process. In addition, Process Engineering is responsible for the technical elements of process production equipment and devices, as well as the further development of the processes during infrastructure expansion in Marly.
Dr. Maëlle Bochud – PhD in Virology, University of Bern
Dr. Matthias Burgener – PhD in Chemistry and Biochemistry, University of Bern; previously: Analyst at Geistlich Pharma AG
Laura Chatagny – Master of Science in Biomedical Sciences, University of Bern
Mauro Consonni – Machine Fitter with Federal Certificate of Competence; previously: Regional Sales Manager at Zumbach Electronics AG
Fabio D’Angelo – Master of Science in Chemistry and Molecular Sciences, University of Bern
Jonas Hosch – Graduate Chemical Process Engineer, Technical University Bergakademie Freiberg
Baptiste Overney – Master of Science HES-SO in Life Sciences; previously: Scientific Collaborator at the School of Engineering and Architecture of Fribourg
Dr. Pascal Richard – PhD in Chemistry, University of Basel; previously: Facility Compliance Associate at Idorsia Pharmaceuticals Ltd
Dr. Thomas Schick – PhD in Biochemistry, University of Bern
Dr. Christoph Steininger – PhD in Bionanotechnology, University of Vienna and University of Singapore; previously: Junior Scientist at the Austrian Institute of Technology GmbH, Vienna
Lucas Wey – Master of Science in Biomedical Engineering, University of Basel